Carcinogenesis Advance Access published online on January 16, 2004
Carcinogenesis, doi:10.1093/carcin/bgh074
© 2004 by Oxford University Press
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CARCINOGENESIS
1 Colorectal Section, Department of Surgery, Chang Gung Memorial Hospital, Lin-ko, Taiwan
* Corresponding author. E-mail: llhsieh{at}mail.cgu.edu.tw.
Received 5 September 2003
; revised 18 December 2003
; accepted 19 December 2003
At least two forms of genomic instability have been described in colorectal cancers (CRCs): microsatellite instability (MIN), which is characterized by a high frequency of microsatellite instability (MSI-H) and chromosomal instability (CIN) which is characterized by losses and gains of chromosomes (aneuploidy), as well as chromosome rearrangements. Morphological and molecular heterogeneity within MIN(-) CRCs have been described, but the distinctions between MIN(-) tumors with CIN and those without CIN remain largely unknown. We studied 179 colorectal cancers to elucidate the clinicopathological characteristics and molecular events in CRCs arising along these pathways. Loss of heterozygosity, microsatellite instability, DNA content, mutation of p53 and K-ras, and expression of p53, hMLH1, and hMSH2 were examined. We found that a subtype of tumors (17%) with MIN(-) and CIN(-), differed from MIN(-)CIN(+) tumors with respect to clinicopathological and genetic characteristics. This subtype was associated with a greater frequency of poorly differentiated and/or mucinous tumors (26%). This subtype of tumors had an extremely low p53 gene mutation rate (11%) and a relatively high p53 protein accumulation rate (55%). The dissociation between the p53 gene mutation and protein accumulation suggests that stabilization of p53 protein in the absence of p53 gene mutation may be an important event on a distinct pathway.
Microsatellite instability, Colorectal cancer, Aneuploidy, Heterozygosity, Carcinogenesis
Colorectal cancer without high microsatellite instability and chromosomal instability - an alternative genetic pathway to human colorectal cancer
2 Department of Public Health, Chang Gung University, Tao-Yuan, Taiwan
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
E. S. McKenna, C. G. Sansam, Y.-J. Cho, H. Greulich, J. A. Evans, C. S. Thom, L. A. Moreau, J. A. Biegel, S. L. Pomeroy, and C. W. M. Roberts Loss of the Epigenetic Tumor Suppressor SNF5 Leads to Cancer without Genomic Instability Mol. Cell. Biol., October 15, 2008; 28(20): 6223 - 6233. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Le Gouvello, S Bastuji-Garin, N Aloulou, H Mansour, M-T Chaumette, F Berrehar, A Seikour, A Charachon, M Karoui, K Leroy, et al. High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas Gut, June 1, 2008; 57(6): 772 - 779. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Schmidt, J. Wu, and R. D. Kolodner Control of Translocations between Highly Diverged Genes by Sgs1, the Saccharomyces cerevisiae Homolog of the Bloom's Syndrome Protein. Mol. Cell. Biol., July 1, 2006; 26(14): 5406 - 5420. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Camps, G. Armengol, J. del Rey, J. J. Lozano, H. Vauhkonen, E. Prat, J. Egozcue, L. Sumoy, S. Knuutila, and R. Miro Genome-wide differences between microsatellite stable and unstable colorectal tumors Carcinogenesis, March 1, 2006; 27(3): 419 - 428. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Putnam, V. Pennaneach, and R. D. Kolodner Saccharomyces cerevisiae as a Model System To Define the Chromosomal Instability Phenotype Mol. Cell. Biol., August 15, 2005; 25(16): 7226 - 7238. [Abstract] [Full Text] [PDF] |
||||
![]() |
C M Wright, O F Dent, R C Newland, M Barker, P H Chapuis, E L Bokey, J P Young, B A Leggett, J R Jass, and G A Macdonald Low level microsatellite instability may be associated with reduced cancer specific survival in sporadic stage C colorectal carcinoma Gut, January 1, 2005; 54(1): 103 - 108. [Abstract] [Full Text] [PDF] |
||||
![]() |
A J M Watson Apoptosis and colorectal cancer Gut, November 1, 2004; 53(11): 1701 - 1709. [Full Text] [PDF] |
||||


